References
- Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348(19):1875–1883.
- Osserman EF, DiRe LB, DiRe J, et al. Identical twin marrow transplantation in multiple myeloma. Acta Haematol. 1982;68(3):215–223.
- Dhakal B, Vesole D, Hari P. Allogeneic stem cell transplantation for multiple myeloma: is there a future? Bone Marrow Transplant. 2016;51(4):492–500.
- Bensinger WI, Demirer T, Buckner CD, et al. Syngeneic marrow transplantation in patients with multiple myeloma. Bone Marrow Transplant. 1996;18(3):527–531.
- Gahrton G, Svensson H, Björkstrand B, et al. Syngeneic transplantation in multiple myeloma – a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1999;24(7):741–745.
- Bashey A, Pérez WS, Zhang MJ, et al. Comparison of twin and autologous transplants for multiple myeloma. Biol Blood Marrow Transplant. 2008;14(10):1118–1124.
- Mohyuddin GR, Faisal MS, Badar T, et al. A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center. Leuk Lymphoma. 2018;59(2):515–518.
- Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia. 2006;20(9):1467–1473.
- Murphy M, Hey K. Twinning rates. Lancet. 1997;349(9062):1398–1399.